Interferon alfa-2b biosimilar (Probiomed)

干扰素α-2b生物类似药（Probiomed）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b biosimilar (Probiomed)
Drug Alias Namerh IFN alfa 2b (Probiomed)干扰素α-2b生物仿制药（Probiomed）Recombinant human interferon alfa-2b (Probiomed)Urifron
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple MyelomaMelanomaLeukemia, Hairy Cell +[7] 
Global Approved IndicationsMultiple MyelomaMelanomaLeukemia, Hairy Cell +[7] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date2006/03/01
Country/TerritoryMexico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesProbiomed
China Registration ClassN/A

Develop Information

Active CompaniesProbiomed
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaMelanomaLeukemia, Hairy Cell +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A